Susquehanna International Group’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.33M | Sell |
850,505
-85,414
| -9% | -$270K | ﹤0.01% | 5814 |
|
|
2025
Q4 | $3.46M | Sell |
935,919
-18,530
| -2% | -$59.9K | ﹤0.01% | 4625 |
|
|
2025
Q3 | $2.53M | Buy |
954,449
+117,988
| +14% | +$228K | ﹤0.01% | 5298 |
|
|
2025
Q2 | $823K | Buy |
836,461
+73,828
| +10% | +$73.9K | ﹤0.01% | 7944 |
|
|
2025
Q1 | $1.1M | Buy |
762,633
+34,401
| +5% | +$63.4K | ﹤0.01% | 7009 |
|
|
2024
Q4 | $1.6M | Sell |
728,232
-27,795
| -4% | -$64.8K | ﹤0.01% | 5796 |
|
|
2024
Q3 | $1.25M | Buy |
756,027
+237,069
| +46% | +$479K | ﹤0.01% | 6308 |
|
|
2024
Q2 | $1.15M | Sell |
518,958
-1,526,811
| -75% | -$3.59M | ﹤0.01% | 6254 |
|
|
2024
Q1 | $5.48M | Buy |
2,045,769
+655,495
| +47% | +$1.59M | 0.01% | 3494 |
|
|
2023
Q4 | $4.16M | Buy |
1,390,274
+792,434
| +133% | +$1.03M | 0.01% | 4032 |
|
|
2023
Q3 | $586K | Sell |
597,840
-45,232
| -7% | -$65.4K | ﹤0.01% | 7860 |
|
|
2023
Q2 | $894K | Buy |
643,072
+335,061
| +109% | +$468K | ﹤0.01% | 6959 |
|
|
2023
Q1 | $490K | Buy |
308,011
+150,776
| +96% | +$778K | ﹤0.01% | 8618 |
|
|
2022
Q4 | $980K | Buy |
157,235
+132,384
| +533% | +$947K | ﹤0.01% | 6231 |
|
|
2022
Q3 | $167K | Buy |
+24,851
| New | +$171K | ﹤0.01% | 11096 |
|
|
2022
Q2 | – | Sell |
-97,136
| Closed | -$551K | – | 13244 |
|
|
2022
Q1 | $451K | Buy |
+97,136
| New | +$417K | ﹤0.01% | 9237 |
|
|
2021
Q4 | – | Sell |
-41,597
| Closed | -$333K | – | 13368 |
|
|
2021
Q3 | $501K | Sell |
41,597
-158,249
| -79% | -$2.3M | ﹤0.01% | 9395 |
|
|
2021
Q2 | $4.23M | Buy |
199,846
+22,530
| +13% | +$543K | ﹤0.01% | 4340 |
|
|
2021
Q1 | $4.97M | Buy |
177,316
+129,040
| +267% | +$3.81M | 0.01% | 3927 |
|
|
2020
Q4 | $1.25M | Buy |
48,276
+30,191
| +167% | +$904K | ﹤0.01% | 6158 |
|
|
2020
Q3 | $672K | Sell |
18,085
-118,154
| -87% | -$4.68M | ﹤0.01% | 7046 |
|
|
2020
Q2 | $6.99M | Sell |
136,239
-52,690
| -28% | -$2.2M | 0.01% | 2575 |
|
|
2020
Q1 | $5.96M | Buy |
188,929
+64,091
| +51% | +$3.38M | 0.01% | 2350 |
|
|
2019
Q4 | $7.44M | Buy |
124,838
+27,119
| +28% | +$1.22M | 0.02% | 2447 |
|
|
2019
Q3 | $3.58M | Sell |
97,719
-42,265
| -30% | -$1.67M | 0.01% | 3208 |
|
|
2019
Q2 | $6.51M | Buy |
139,984
+30,940
| +28% | +$1.45M | 0.02% | 2376 |
|
|
2019
Q1 | $4.38M | Buy |
+109,044
| New | +$4.89M | 0.02% | 2614 |
|
|
2018
Q3 | – | Sell |
-198,000
| Closed | -$9.09M | – | 9676 |
|
|
2018
Q2 | $7.76M | Buy |
+198,000
| New | +$10M | 0.03% | 2200 |
|
|
2018
Q1 | – | Sell |
-115,879
| Closed | -$8.51M | – | 9653 |
|
|
2017
Q4 | $7.63M | Buy |
+115,879
| New | +$6.24M | 0.03% | 2077 |
|
|
2017
Q1 | – | Sell |
-49,983
| Closed | -$1.14M | – | 9261 |
|
|
2016
Q4 | $626K | Sell |
49,983
-51,085
| -51% | -$608K | ﹤0.01% | 6519 |
|
|
2016
Q3 | $1.4M | Buy |
101,068
+44,424
| +78% | +$503K | 0.01% | 4171 |
|
|
2016
Q2 | $560K | Sell |
56,644
-57,910
| -51% | -$960K | ﹤0.01% | 5932 |
|
|
2016
Q1 | $1.94M | Sell |
114,554
-10,058
| -8% | -$162K | 0.01% | 3833 |
|
|
2015
Q4 | $2.77M | Sell |
124,612
-223,488
| -64% | -$5.64M | 0.01% | 3436 |
|
|
2015
Q3 | $8.21M | Buy |
348,100
+92,718
| +36% | +$5.82M | 0.02% | 2057 |
|
|
2015
Q2 | $20.9M | Buy |
255,382
+82,046
| +47% | +$8.03M | 0.04% | 1266 |
|
|
2015
Q1 | $16.1M | Buy |
173,336
+166,887
| +2,588% | +$10.8M | 0.04% | 1420 |
|
|
2014
Q4 | $261K | Buy |
+6,449
| New | +$197K | ﹤0.01% | 8368 |
|
Other funds holding ESPR
WA
TSC
O
VCM
